Canada's Supreme Court upholds GSK's zidovudine patent.
Publication Date: 09-DEC-02
Publication Title: Pharma Marketletter
Format: Online
Company: Reuters Group PLC

Read this article now
Try Goliath Business News - FREE!
You can view this article PLUS...

  • Over 5 million business articles
  • Hundreds of the most trusted magazines, newswires, and journals (see list)
  • Premium business information that is timely and relevant
  • Unlimited Access

Now for a Limited Time, try Goliath Business News
Free for 7 Days!

Tell Me More   Terms and Conditions

Purchase this article for $4.95

Description

The Supreme Court of Canada has upheld Anglo-American drug major GlaxoSmithKline's Canadian patent for the anti-AIDS drug Retrovir (zidovudine, also known as AZT) and has denied generic drug companies the right to produce cheaper versions, reports Reuters.

In claims that have been echoed in other countries, Canadian generic drugmakers...



More articles from Pharma Marketletter
New ABOLmed plant in Siberia., December 09, 2002
Beaufour Ipsen set for $10.5M sales in Romania., December 09, 2002
IsoTis share tendered in Modex deal., December 09, 2002
Grindeks ownership change., December 09, 2002
BTG invests in Iclectus., December 09, 2002

Looking for additional articles?
Click here to search our database of over 3 million articles.